Biochanin A and CPe-III Peptide Improved Hepatic Inflammation by Regulating the Hepatic Lipid Metabolic Pathways in Diet-Induced Obese Mice

Abstract

Biochanin A (BCA) and CPe-III peptide, which both exist in chickpea (Cicer arietinum L.), possess significant antihyperlipidemic properties. However, the actual mechanisms of those compounds in inhibiting the dysregulation of lipid metabolism and complicated inflammation have not been well characterized. This study investigated the effects of BCA, CPe-III peptide, and combined BCA and CPe-III peptide (BC) on the expression of genes involved in hepatic lipid and inflammation metabolism. Results demonstrated that BCA, CPe-III peptide, and BC significantly attenuated hepatitis and hyperlipidemia by downregulating those genes involved in pro-inflammatory cytokines (TNF-α), hepatic fatty acid (FA) synthesis (ACC1 and FAS), cholesterol metabolism (SREBP2, HMGCR, and PCSK9), and upregulating key regulators involved in FA oxidation (PPARα and FABP1), lipolysis (ATGL), LDLR, reverse cholesterol transport (ABCA1, SR-B1, and LXRα), and cholesterol catabolism (CYP7A1). Moreover, they also altered the expression of lipid metabolism-related proteins, including SREBP2, PCSK9, LDLR, ABCA1, and CYP7A1. Finally, these results revealed that the combination treatment of BCA and CPe-III peptide resulted in greater antihyperlipidemic activity compared with individual compounds.

Keywords

Biochanin A / CPe-III peptide / Lipid metabolism / Inflammation / Gene expression / Protein expression

References

[1] De Sereday MS, Gonzalez C, Giorgini D, et al. Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab, 2004, 30(4): 335-339.

[2] Kwon EY, Jung UJ, Park T, et al. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes, 2015, 64(5): 1658-1669.

[3] Maggo SDS, Kennedy MA, Clark DWJ. Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf, 2011, 34(1): 1-19.

[4] Wang KL, Liu CJ, Chao TF, et al. Statins, risk of diabetes, and implications on outcomes in the general population. J Am Coll Cardiol, 2012, 60(14): 1231-1238.

[5] Afman L, Müller M. Nutrigenomics: from molecular nutrition to prevention of disease. J Am Diet Assoc, 2006, 106(4): 569-576.

[6] Mao J, DeMayo FJ, Li HG, et al. Liver-specific deletion of acetyl-Coa carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA, 2006, 103(22): 8552-8557.

[7] Semenkovich CF. Regulation of fatty acid synthase (FAS). Prog Lipid Res, 1997, 36(1): 43-53.

[8] Lu YF, Xu YY, Jin F, et al. Icariin is a PPARα activator inducing lipid metabolic gene expression in mice. Molecules, 2014, 19(11): 18179-18191.

[9] Muoio DM, Maclean PS, Lang DB, et al. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Evidence for compensatory regulation by PPARα. J Biol Chem, 2002, 277(29): 26089-26097.

[10] Feingold KR, Adi S, Staprans I, et al. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Am J Physiol, 1990, 259(2): 177-184.

[11] Popa C, Netea MG, van Riel PLM, et al. The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res, 2007, 48(4): 751-762.

[12] Chen ZY, Jiao R, Ma KY. Cholesterol-lowering nutraceuticals and functional foods. J Agric Food Chem, 2008, 56(19): 8761-8773.

[13] Sato R. Sterol metabolism and SREBP activation. Arch Biochem Biophys, 2010, 501(2): 177-181.

[14] Guo YL, Zhang W, Li JJ. PCSK9 and lipid lowering drugs. Clin Chim Acta, 2014, 437(1): 66-71.

[15] Chiang JYL. Bile acids: regulation of synthesis. J Lipid Res, 2009, 50(10): 1955-1966.

[16] Bonamassa B, Moschetta A. Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol Metab, 2013, 24(3): 120-128.

[17] Khalil A, Berrougui H, Pawelec G, et al. Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer’s disease. Mech Ageing Dev, 2012, 133(1): 20-29.

[18] Harini R, Sundaresan A, Pugalendi KV. Antihyperlipidemic effect of biochanin A on streptozotocin induced diabetic rats. J Pharm Res, 2012, 5(1): 707-710.

[19] Park HS, Hur HJ, Kim SH, et al. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Mol Nutr Food Res, 2016, 60(9): 1944-1955.

[20] Xue ZH, Gao J, Zhang ZJ, et al. Antihyperlipidemic and antitumor effects of chickpea albumin hydrolysate. Plant Food Hum Nutr, 2012, 67(4): 393-400.

[21] Kou XH, Gao J, Xue ZH, et al. Purification and identification of antioxidant peptides from chickpea (Cicer Arietinum L.) albumin hydrolysates. LWT-Food. Sci Technol, 2013, 50(2): 591-598.

[22] Miller L (2010) Analyzing gels and western blots with ImageJ. Lukemiller. Org. http://lukemiller.org/index.php/2010/11/analyzing-gels-and-western-blots-with-image-j/. Accessed 1 Mar 2016

[23] Norris GH, Porter CM, Jiang C, et al. Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. J Nutr Biochem, 2017, 40: 36-43.

[24] Zhang RJ, Yu Y, Hu S, et al. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. Nutr Res, 2016, 36(9): 1022-1030.

[25] Lira FS, Rosa Neto JC, Antunes BMM, et al. The relationship between inflammation, dyslipidemia and physical exercise: from the epidemiological to molecular approach. Curr Diabetes Rev, 2014, 10(6): 391-396.

[26] Galli C, Calder PC. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab, 2009, 55(1–3): 123-139.

[27] Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends Cardiovas Med, 2005, 15(4): 158-161.

[28] Breikaa RM, Algandaby MM, El-Demerdash E, et al. Multimechanistic antifibrotic effect of biochanin A in rats: implications of proinflammatory and profibrogenic mediators. PLoS ONE, 2013, 8(7): e69276

[29] Boden G, She PX, Mozzoli M, et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes, 2006, 54(12): 3458-3465.

[30] Freigang S, Ampenberger F, Weiss A, et al. Fatty acid-induced mitochondrial uncoupling elicits inflammasome- independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat Immunol, 2013, 14(10): 1045-1053.

[31] Guzmán C, Benet M, Pisonero-Vaquero S, et al. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim Biophys Acta, 2013, 1831(4): 803-818.

[32] Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta, 2011, 1812(8): 1007-1022.

[33] Qiu LX, Ye H, Chen LM, et al. Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARα. Phytother Res, 2012, 26(6): 860-864.

[34] Mueller M, Hobiger S, Jungbauer A. Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor α and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause, 2010, 17(2): 379-387.

[35] Le NA, Brown WV. Grundy SM. Triglyceride-rich lipoproteins. Atlas of atherosclerosis and metabolic syndrome, 2011, New York, USA: Springer 59-91.

[36] Perona JS, Covas MI, Fitó M, et al. Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects. J Nutr Biochem, 2010, 21(9): 892-898.

[37] Yang JH, Bang MA, Jang CH, et al. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression. J Nutr Biochem, 2015, 26(11): 1393-1400.

[38] Horton JD, Shah NA, Warrington JA, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA, 2003, 100(21): 12027-12032.

[39] Maxwell KN, Soccio RE, Duncan EM, et al. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res, 2003, 44(11): 2109-2119.

[40] Liu Q, Guo Y, Gui YJ, et al. Is sEHi lowering LDL-C by reducing expression of PCSK9 through SREBP2 pathway?. Int J Cardiol, 2016, 207: 361-362.

[41] Li H, Dong B, Park SW, et al. Hepatocyte nuclear factor 1α plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. J Biol Chem, 2009, 284(42): 28885-28895.

[42] Dullaart RP, Annema W, Tio RA, et al. The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol. Clin Chim Acta, 2014, 433(7): 34-38.

[43] De Fabiani E, Mitro N, Anzulovich AC, et al. The negative effects of bile acids and tumor necrosis factor-α on the transcription of cholesterol 7α-hydroxylase gene (cyp7a1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem, 2001, 276(33): 30708-30716.

[44] Field FJ, Watt K, Mathur SN. TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. J Lipid Res, 2010, 51(6): 1407-1415.

[45] Khovidhunkit W, Moser AH, Shigenaga JK, et al. Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J Lipid Res, 2001, 42(10): 1636-1644.

[46] Wiriyaphan C, Xiao H, Decker EA, et al. Chemical and cellular antioxidative properties of threadfin bream (Nemipterus spp.) surimi byproduct hydrolysates fractionated by ultrafiltration. Food Chem, 2015, 167(11): 7-15.

[47] Chi CF, Wang B, Wang YM, et al. Isolation and characterization of three antioxidant peptides from protein hydrolysate of bluefin leatherjacket (Navodon septentrionalis) heads. J Funct Foods, 2015, 12: 1-10.

[48] Feng LJ, Yu CH, Ying KJ, et al. Hypolipidemic and antioxidant effects of total flavonoids of Perilla Frutescens leaves in hyperlipidemia rats induced by high-fat diet. Food Res Int, 2011, 44(1): 404-409.